KES
Search
- Page Path
- HOME > Search
Case Reports
- Adrenal gland
- Pheochromocytoma with Markedly Abnormal Liver Function Tests and Severe Leukocytosis
- Chai Ryoung Eun, Jae Hee Ahn, Ji A Seo, Nan Hee Kim
- Endocrinol Metab. 2014;29(1):83-90. Published online March 14, 2014
- DOI: https://doi.org/10.3803/EnM.2014.29.1.83
- 3,612 View
- 34 Download
- 5 Web of Science
- 6 Crossref
-
Abstract
PDF
PubReader Pheochromocytoma is a rare neuroendocrine tumor arising from the medulla of the adrenal glands, which causes an overproduction of catecholamines. The common symptoms are headache, palpitations, and sweating; however, various other clinical manifestations might also be present. Accurate diagnosis of pheochromocytoma is important because surgical treatment is usually successful, and associated clinical problems are reversible if treated early. A 49-year-old man with a history of uncontrolled hypertension and diabetes mellitus presented with chest pain, fever, and sweating. His liver function tests and white blood cell counts were markedly increased and his echocardiography results suggested stress-induced cardiomyopathy. His abdominal computed tomography showed a 5×5-cm-sized tumor in the left adrenal gland, and laboratory tests confirmed catecholamine overproduction. After surgical resection of the left adrenal gland, his liver function tests and white blood cell counts normalized, and echocardiography showed normal cardiac function. Moreover, his previous antihypertensive regimen was deescalated, and his previously uncontrolled blood glucose levels normalized without medication.
-
Citations
Citations to this article as recorded by
- Liver Transplantation for Fulminant Hepatic Failure Precipitated by Pheochromocytoma Crisis in the Setting of Using Garcinia cambogia Weight Loss Supplement: A Case Report
Motaz A Selim, Krystal Weierstahl, Calvin Eriksen, Terra Pearson, Harvey Woehlck
Cureus.2023;[Epub] CrossRef - Pheochromocytoma presenting with severe abdominal pain and abnormal liver enzymes
Mhd Baraa Habib, Mohamed Abdelrazek, Sali Alatasi, Mouhand F. H. Mohamed, Hamda Ali, Mohamad Khair Hamad
Clinical Case Reports.2021;[Epub] CrossRef - A cardiogenic shock in PICU turned out to be a bilateral pheochromocytoma: A case report
Jay Shah, Zinkal Patel, Shradha Patel, Amit Kumar
Journal of Pediatric Critical Care.2021; 8(5): 255. CrossRef - Endocrine Diseases and the Liver
Miguel Malespin, Ammar Nassri
Clinics in Liver Disease.2019; 23(2): 233. CrossRef - Pheochromocytoma crisis presenting with hypotension, hemoptysis, and abnormal liver function
Renhua Wu, Nanwei Tong, Xinlei Chen, Shishi Xu, Fang Zhang, Lizhi Tang, Yuwei Zhang
Medicine.2018; 97(25): e11054. CrossRef - Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47. CrossRef
- Liver Transplantation for Fulminant Hepatic Failure Precipitated by Pheochromocytoma Crisis in the Setting of Using Garcinia cambogia Weight Loss Supplement: A Case Report
- Two Cases of Acromegaly with Empty Sella Syndrome Treated by Long-Acting Release Octreotide.
- Dong Jin Kim, Young Jin Seo, Nam Hoon Kim, Hye Soo Chung, Chai Ryoung Eun, Hye Jung Choi, Hye Sook Kim, Sae Jeong Yang, Juri Park, Hye Jin Yoo, Soo Yeon Park, Yun Jeong Lee, Ohk Hyun Ryu, Kye Won Lee, Hee Young Kim, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi
- J Korean Endocr Soc. 2007;22(2):135-141. Published online April 1, 2007
- DOI: https://doi.org/10.3803/jkes.2007.22.2.135
- 2,009 View
- 27 Download
-
Abstract
PDF
- Two cases of typical acromegaly with empty sella syndrome presented to our institution. In the natural course of untreated pituitary adenoma, empty sella syndrome may result from necrosis by infarction or from hemorrhage of the pituitary gland. In our patients, the secretion of growth hormone continued in spite of the existence of empty sella syndrome. In one case, we confirmed the hypersecretion of growth hormone from sella by jugular vein sampling. Medical therapy with somatostatin analogue was attempted because there was no obvious mass in the sella. After 6~12 months of treatment with long-acting release octreotide, clinical features in our patients were improved, and the level of growth hormone and IGF-1 were also normalized.
First
Prev
